Aberrant or increased expression of COX-2 and its major metabolite, PGE2, are found in several malignancies including non small cell lung carcinoma (NSCLC) in which they promote metastatic development [38]. The gene discussed is PTGS2; the disease is non-small cell lung carcinoma.